SEARCH

SEARCH BY CITATION

References

  • Alonso A. C., Grundke-Iqbal I. and Iqbal K. (1996) Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2, 783787.
  • Alonso A., Zaidi T., Novak M., Grundke-Iqbal I. and Iqbal K. (2001) Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments. Proc. Natl Acad. Sci. USA 98, 69236928.
  • Arioka M., Tsukamoto M., Ishiguro K., Kato R., Sato K., Imahori K. and Uchida T. (1993) Tau protein kinase II is involved in the regulation of the normal phosphorylation state of tau protein. J. Neurochem. 60, 461468.
  • Bhaskar K., Yen S. H. and Lee G. (2005) Disease-related modifications in tau affect the interaction between Fyn and Tau. J. Biol. Chem. 280, 35 11935 125.
  • Biernat J., Gustke N., Drewes G., Mandelkow E. M. and Mandelkow E. (1993) Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding. Neuron 11, 153163.
  • Bramblett G. T., Goedert M., Jakes R., Merrick S. E., Trojanowski J. Q. and Lee V. M. (1993) Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10, 10891099.
  • Buee L., Bussiere T., Buee-Scherrer V., Delacourte A. and Hof P. R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33, 95130.
  • Derkinderen P., Scales T. M., Hanger D. P., et al. (2005) Tyrosine 394 is phosphorylated in Alzheimer's paired helical filament tau and in fetal tau with c-Abl as the candidate tyrosine kinase. J. Neurosci. 25, 65846593.
  • Goedert M., Spillantini M. G., Cairns N. J. and Crowther R. A. (1992) Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms. Neuron 8, 159168.
  • Grundke-Iqbal I., Iqbal K., Tung Y. C., Quinlan M., Wisniewski H. M. and Binder L. I. (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl Acad. Sci. USA 83, 49134917.
  • Hanger D. P., Betts J. C., Loviny T. L., Blackstock W. P. and Anderton B. H. (1998) New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry. J. Neurochem. 71, 24652476.
  • Hasegawa M., Morishima-Kawashima M., Takio K., Suzuki M., Titani K. and Ihara Y. (1992) Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain. J. Biol. Chem. 267, 17 04717 054.
  • Hasegawa M., Jakes R., Crowther R. A., Lee V. M., Ihara Y. and Goedert M. (1996) Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein. FEBS Lett. 384, 2530.
  • He T. C., Zhou S., Da Costa L. T. YuJ., Kinzler K. W. and Vogelstein B. (1998) A simplified system for generating recombinant adenoviruses. Proc. Natl Acad. Sci. USA 95, 25092514.
  • Hutton M., Lendon C. L., Rizzu P., et al. (1998) Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393, 702705.
  • Ikezu T., Luo X., Weber G. A., Zhao J., McCabe L., Buescher J. L., Ghorpade A., Zheng J. and Xiong H. (2003) Amyloid precursor protein-processing products affect mononuclear phagocyte activation: pathways for sAPP- and Abeta-mediated neurotoxicity. J. Neurochem. 85, 925934.
  • Imahori K. and Uchida T. (1997) Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J. Biochem. (Tokyo) 121, 179188.
  • Iqbal K., Grundke-Iqbal I., Smith A. J., George L., Tung Y. C. and Zaidi T. (1989) Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease. Proc. Natl Acad. Sci. USA 86, 56465650.
  • Ishiguro K., Omori A., Takamatsu M., Sato K., Arioka M., Uchida T. and Imahori K. (1992) Phosphorylation sites on tau by tau protein kinase I, a bovine derived kinase generating an epitope of paired helical filaments. Neurosci. Lett. 148, 202206.
  • Jackson G. R., Wiedau-Pazos M., Sang T. K., Wagle N., Brown C. A., Massachi S. and Geschwind D. H. (2002) Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron 34, 509519.
  • Kayser J. P., Vallet J. L. and Cerny R. L. (2004) Defining parameters for homology-tolerant database searching. J. Biomol. Tech 15, 285295.
  • Kosik K. S., Orecchio L. D., Binder L., Trojanowski J. Q., Lee V. M. and Lee G. (1988) Epitopes that span the tau molecule are shared with paired helical filaments. Neuron 1, 817825.
  • Kozak M. (1986) Point mutations define a sequence flanking the AUG initiator codon that modulates translation by eukaryotic ribosomes. Cell 44, 283292.
  • Lee V. M., Goedert M. and Trojanowski J. Q. (2001) Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24, 11211159.
  • Lee G., Thangavel R., Sharma V. M., Litersky J. M., Bhaskar K., Fang S. M., Do L. H., Andreadis A., Van Hoesen G. and Ksiezak-Reding H. (2004) Phosphorylation of tau by fyn: implications for Alzheimer's disease. J. Neurosci. 24, 23042312.
  • Li G., Yin H. and Kuret J. (2004) Casein kinase 1 delta phosphorylates tau and disrupts its binding to microtubules. J. Biol. Chem. 279, 15 93815 945.
  • Manning G., Whyte D. B., Martinez R., Hunter T. and Sudarsanam S. (2002) The protein kinase complement of the human genome. Science 298, 19121934.
  • Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Titani K. and Ihara Y. (1995a) Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270, 823829.
  • Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Watanabe A., Titani K. and Ihara Y. (1995b) Hyperphosphorylation of tau in PHF. Neurobiol. Aging 16, 365371 (discussion 371–380).
  • Napolitano E. W., Chin S. S., Colman D. R. and Liem R. K. (1987) Complete amino acid sequence and in vitro expression of rat NF-M, the middle molecular weight neurofilament protein. J. Neurosci. 7, 25902599.
  • Noble W., Olm V., Takata K., et al. (2003) Cdk5 is a key factor in tau aggregation and tangle formation in vivo. Neuron 38, 555565.
  • Patrick G. N., Zukerberg L., Nikolic M., De La Monte S., Dikkes P. and Tsai L. H. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615622.
  • Pennanen L. and Gotz J. (2005) Different tau epitopes define Abeta (42)-mediated tau insolubility. Biochem. Biophys. Res. Commun. 337, 10971101.
  • Planel E., Sun X. and Takashima A. (2002) Role of GSK-3β in Alzheimer's disease pathology. Drug Dev Res. 56, 491510.
  • Rechsteiner M. and Rogers S. W. (1996) PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21, 267271.
  • Rogers S., Wells R. and Rechsteiner M. (1986) Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science 234, 364368.
  • Sato S., Tatebayashi Y., Akagi T., et al. (2002) Aberrant tau phosphorylation by glycogen synthase kinase-3beta and JNK3 induces oligomeric tau fibrils in COS-7 cells. J. Biol. Chem. 277, 42 06042 065.
  • Sun A., Nguyen X. V. and Bing G. (2002) Comparative analysis of an improved thioflavin-s stain, Gallyas silver stain, and immunohistochemistry for neurofibrillary tangle demonstration on the same sections. J. Histochem. Cytochem. 50, 463472.
  • Thompson J. D., Higgins D. G. and Gibson T. J. (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucl. Acids Res. 22, 46734680.
  • Tomizawa K., Omori A., Ohtake A., Sato K. and Takahashi M. (2001) Tau-tubulin kinase phosphorylates tau at Ser-208 and Ser-210, sites found in paired helical filament-tau. FEBS Lett. 492, 221227.
  • Vega I. E., Cui L., Propst J. A., Hutton M. L., Lee G. and Yen S. H. (2005) Increase in tau tyrosine phosphorylation correlates with the formation of tau aggregates. Brain Res. Mol. Brain Res. 138, 135144.
  • Yamamoto M., Horiba M., Buescher J. L., Huang D., Gendelman H. E., Ransohoff R. M. and Ikezu T. (2005) Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition. Am. J. Pathol. 166, 14751485.
  • Zheng-Fischhofer Q., Biernat J., Mandelkow E. M., Illenberger S., Godemann R. and Mandelkow E. (1998) Sequential phosphorylation of Tau by glycogen synthase kinase-3beta and protein kinase A at Thr212 and Ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur. J. Biochem. 252, 542552.